SANUWAVE Health to Host Conference Call and Provide Business Update
SANUWAVE Health (SNWV) is set to hold a conference call on March 2, 2022, at 9:00 am ET, to discuss recent business developments, updates on SEC filings, and strategic initiatives.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
SANUWAVE Health (SNWV) is set to hold a conference call on March 2, 2022, at 9:00 am ET, to discuss recent business developments, updates on SEC filings, and strategic initiatives. Investors can join by dialing 1-877-407-0784 (toll-free) or 1-201-689-8560 (international). A replay will be available until March 9, 2022, using the passcode 13727564. SANUWAVE specializes in non-invasive wound care technologies aimed at enhancing the body's healing processes.
Details
News Market Reaction – SNWV
The recorded move for SNWV in the trading session of this news was +5.88%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANUWAVE will hold a conference call on Wednesday, March 2, 2022 at 9:00 am ET
SUWANEE, GA, Feb. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (SNWV), a leading provider of next-generation wound care products, announced it will hold a conference call on Wednesday, March 2, 2022, at 9:00 am ET to discuss its recent business activity, provide an update on SEC filings and detail strategic initiatives.
Telephone access to the live call will be available by dialing the following numbers:
Toll Free: 1-877-407-0784
International: 1-201-689-8560
A replay of the call can be accessed through March 9, 2022, at:
Toll Free: 1-844-512-2921
International: 1-412-317-6671
Replay Passcode: 13727564
About SANUWAVE Health
SANUWAVE Health (SNWV) is focused on the research, development, and commercialization of its patented, Energy First non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
SANUWAVE’s end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, plastic/cosmetic, and cardiac/endovascular conditions. For more information, please visit. www.SANUWAVE.com.
Investor Relations Contact
SANUWAVE Health, Inc.
Kevin Richardson II
Chairman and Chief Executive Officer
978-922-2447
investorrelations@SANUWAVE.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.